---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-23-001017"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T01:12:06.714988+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Lipella raises CEO and CMO salaries by $50k each

## Summary
- CEO Jonathan Kaufman annual base salary increased by $50,000 to $233,300 effective August 4, 2023.
- CMO Michael Chancellor annual base salary increased by $50,000 to $225,000 effective August 4, 2023.
- Both amendments executed on August 4, 2023; all other terms of existing employment agreements remain unchanged.
- The salary increases are reflected in amendments to employment agreements originally dated July 17, 2020.

## SEC filing metadata
- accession: 0001753926-23-001017
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392623001017/0001753926-23-001017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392623001017/g083697_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-23-001017
- JSON: https://secwatch.observer/filing/0001753926-23-001017.json
- Plain text: https://secwatch.observer/filing/0001753926-23-001017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.